MICHAEL SPIVAK: Open Payments
NPI 1437499076 · MASON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,753 in 141 payments from 29 companies in 2025. Trend: 2023 $3,428 · 2024 $3,295 · 2025 $2,753
Food & beverage: $2,753
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 17 | $268 |
| KYOWA KIRIN, INC. | 8 | $248 |
| Novo Nordisk Inc | 16 | $229 |
| Neurocrine BioSciences, Inc. | 5 | $190 |
| Amgen Inc. | 9 | $164 |
| RECORDATI_RARE_DISEASES_INC. | 7 | $158 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $149 |
| ABBVIE INC. | 12 | $140 |
| BETA BIONICS, INC. | 5 | $112 |
| Insulet Corporation | 5 | $89 |
Products named: JARDIANCE, MOUNJARO, CRENESSITY, REPATHA, ISTURISA, Ozempic, CRYSVITA, iLet Bionic Pancreas.
Industry payments across OH — which companies pay providers there.
